Cannon Milani, M.D. Brown University Fellowship, Hematology/Oncology. Boston University Residency, Internal Medicine

Size: px
Start display at page:

Download "Cannon Milani, M.D. Brown University Fellowship, Hematology/Oncology. Boston University Residency, Internal Medicine"

Transcription

1 Cannon Milani, M.D. CONTACT INFORMATION Professional Address: 1043 Elm Avenue, # 104 Long Beach, CA P: F: POSTDOCTORAL TRAINING Brown University Fellowship, Hematology/Oncology Boston University Residency, Internal Medicine EDUCATION Jagiellonian University Medical College Krakow, Poland; Medical Doctorate University of California-Irvine Bachelor of Arts, Social Science PROFESSIONAL EXPERIENCE Oncology Institute Private Practice: Hematology and Medical Oncology Long Beach, CA East Bay Partners in Cancer Care Private Practice: Hematology and Medical Oncology Dublin, CA National Institutes of Health; Bethesda, MD 11/2005 Visiting Resident, Bone Marrow Transplantation Unit Clinical inpatient and outpatient elective (four weeks) Supervisor: Dr. Cindy Dunbar Washington Hospital Center; Washington DC 08/2005 Visiting Resident, Hematology and Oncology Department Hematology inpatient and consultation service (four weeks) Supervisor: Dr. Vera Malkovska University of California-Irvine Medical Center; Orange, CA 08-09/2003 Hematology consultation service (four weeks); Surgical Oncology (four weeks) Supervisors: Dr. Misagh Karimi and Dr. Sean Cao

2 Mayo Clinic; Scottsdale, AZ 10/2003 Department of Internal Medicine Sub-internship rotation (four weeks) Supervisor: Dr. Keith J. Cannon MEDICAL LICENSURE Medical Board of California, License # A CERTIFICATIONS Medical Oncology Board Certified American Board of Internal Medicine PROFESSIONAL AWARDS AND RECOGNITION Invited Speaker- BIT's 2nd Annual International Congress of Antibodies 03/2010 Topic: Novel Monoclonal Target Discovery; Beijing, China Invited Manuscript Reviewer- Surgical and Radiologic Anatomy 05/2009 American Society of Bone Marrow Transplantation (ASBMT) 2009&2010 Travel Grant Recipient for Outstanding Research Contribution Young Investigator Award In Clinical Science 11/ th Annual Brown University Research Symposium American College of Physicians 05/2005 Oral Abstract Competition Winner; Rhode Island Regional Chapter RESEARCH EXPERIENCE Stem Cell Plasticity Laboratory Research Associate Engaged in studies involving conversion of marrow stem cells to other non-hematopoietic cells. Assessed the potential of bone marrow transplantation for muscle regeneration in murine in-vitro models using the bone marrow of Green Fluorescent Protein Positive (GFP+) mice. Mentors: Dr. Gerald Colvin and Dr. Peter Quesenberry (Brown University) ORIGINAL ARTICLES (PUB MED) 1. Tuncer HH, Rana N, Milani C, Darko A, Al-Homsi SA. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol Apr 28;18(16):

3 2. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin GA, Butera JN. HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk Apr;11(2): Epub 2011 Apr 8. Review. 3. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma. Oncologist. 2010;15(3): Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. October [Epub ahead of print] 5. Dalia S, MD, Milani C, Castillo J, Mega A, Schiffman F. The Creative Clinician: Fooled by the Fragments: Masquerading Microangiopathy. MedHealth RI. Volume 93 No. 1 January Milani C, Dalia S, Colvin G. Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report. Cases Journal 2009, 2: Castillo J, Perez K, Milani C, Pantanowitz L, Dezube B. HIV-associated peripheral T-cell Lymphoma: A comprehensive review. Journal of HIV Therapy, June 2009; 14(2): Milani C, Castillo J. Veltuzumab, an anti-cd20 mab for the treatment of non-hodgkin's lymphoma, chronic lymphocytic leukemia, and immune thrombocytopenic purpura. Curr Opin Mol Ther Apr; 11(2): Castillo J, Milani C, Mendez-Allwood D. Ofatumumab, a second-generation anti-cd20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders. Expert Opin Investig Drugs Apr; 18(4): Milani C, Constantinou M, Berz D, Butera JN, Colvin GA. Left Sided Inferior Vena Cava Duplication and Venous Thromboembolism. A case report and review of Literature. Journal of Hematology & Oncology 2008, 1: ABSTRACTS A1. Milani C, Al Homsi S. Isolated Epstein-Barr Virus-Induced Central Nervous System Post- Transplantation Lymphoproliferative Disorder Despite Negative Serum PCR. ASBMT Tandem Meetings Feb 2010; Orlando, Florida. A2. Milani C, Colvin G, Quesenberry P. Consolidation Therapy Following Autologous Stem Cell Transplantation for Non-hodgkins and Hodgkins Lymphoma; ASBMT Tandem Meetings Feb 2010; Orlando, Florida. A3. Milani C, Colvin G, Mazur E, and Berz D. Transient Iron Resistance in Severe Iron Deficiency Anemia. Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: Abstract A4. Milani C, Dalia S, and Colvin G. Thromboembolic Complications of IVIG in

4 Hypogammaglobulinemic Patients with CLL. Blood (ASH Annual Meeting Abstracts) Nov 2009; 114: Abstract A5. Milani C, Schiffman F, and Quesenberry P. Neutrophil Platelet Satellitism Revisited: Sidedness and Domain of Neutrophil Associated Platelet Aggregates. Blood (ASH Annual Meeting Abstracts) Nov 2009; 114: Abstract A6. Milani C, Castillo J. HIV-associated Peripheral T-cell lymphoma. Journal of Clinical Oncology 27, 2009 (suppl; abstr e19551) A7. Castillo J, Milani C, et al. HIV-associated Anaplastic Large Cell lymphoma. Journal of Clinical Oncology 27, 2009 (suppl; abstr e19563) A8. Zang Y, Milani C, Pascual S, Treaba D. Accelerated Phase BCR/ABL1 Positive CML In The Setting Of Long-standing JAK-2V617F Positive Polycythemia Vera. College of American Pathology Meeting (CAP), Washington D.C. Oct 2009 A9. Milani C, et. al. Non-Hodgkins Lymphoma and Smoking: A Meta Analysis of Case-Control Studies. Blood (ASH Annual Meeting), Nov 2008; 112: Abstract A10. Milani C, Pascual S, Colvin G. A Retrospective Literature Review of Erythromelalgia and Myeloproliferative Disorders. Blood (ASH Annual Meeting Abstracts), Nov 2008;112: 5264 A11. Pascual S, Milani C, Mitri J, Castillo J. Smoking and Hodgkins Lymphoma: A Meta- Analysis. Blood (ASH Annual Meeting Abstracts), Nov 2008;112: Abstract A12. Milani C, et al. Rituximab in Refractory Thrombotic Thrombocytopenic Purpura. American College of Physicians Abstract Competition Presentation; Washington D.C. Regional Chapter. Washington Hospital Center, Nov 2005 A13. Milani C, et al. Role of Stem Cell Transplantation in Relapsed Non-Hodgkins Lymphoma. American College of Physicians Oral Abstract Competition Winner. Rhode Island Regional Chapter, May 2005 PROFESSIONAL ORGANIZATIONS AND SOCIETIES American Society of Hematology American Society of Clinical Oncology TEACHING EXPERIENCE I. Brown University Warren Alpert Medical School, Course Instructor Integrated Hematology Course for Second-year Medical Students: 2010 II. Brown University, Medical Student Preceptor Program Clinical Mentor: Jason Lambresse from 09/07-03/08; Student: Portia Thurmond from 09/08-01/09

5 BROWN UNIVERSITY TEACHING HOSPITAL LECTURES I. Grand Rounds Presentations: -Future Directions in Glioblastoma Multiforme Therapy 09/2008 -The Pathogenesis of Epstein-Barr Virus in Lymphomas 04/2009 -Controversies in Management of CSI Non-seminoma Germ Cell Tumors 02/2010

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Faculty representative: Neil Weiner, MD Resident representative: Guiherme Rabinowits, MD Revision date: February 28, 2006 Goals

More information

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen Blood Cancers: Progress and Promise Mike Barnett & Khaled Ramadan Division of Hematology Department of Medicine Providence Health Care & UBC Blood Cancers Significant health problem Arise from normal cells

More information

EMERGING THERAPIES FOR BLOOD CANCERS:

EMERGING THERAPIES FOR BLOOD CANCERS: EMERGING THERAPIES FOR BLOOD CANCERS: Case Studies Adherence, Ethics and Other Nursing Management Challenges CONTINUING EDUCATION IS OFFERED FOR THIS ACTIVITY CONTENTS Welcome.............................................................

More information

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American

More information

PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION

PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION ROTATION TITLE Outpatient Adult Oncology PURPOSE The outpatient oncology service will provide the PGY-2 resident with the opportunity to further develop and

More information

Recommended Timing for Transplant Consultation

Recommended Timing for Transplant Consultation REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org

More information

Peking University People's Hospital, Peking University Institute of Hematology

Peking University People's Hospital, Peking University Institute of Hematology Qian Jiang, M.D. Peking University People's Hospital, Peking University Institute of Hematology No. 11 Xizhimen South Street, Beijing, 100044, China. Phone number: 86-10-66583802 Mobile: 86-13611115100

More information

Annual Report Division of Hematology Department of Medicine, Jewish General Hospital April 1, December 31, 2011

Annual Report Division of Hematology Department of Medicine, Jewish General Hospital April 1, December 31, 2011 Annual Report Division of Hematology Department of Medicine, Jewish General Hospital April 1, 2011 - December 31, 2011 I HIGHLIGHTS A) Segal Cancer Center After more than five years of operation in the

More information

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam: Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist

More information

Idelalisib treatment is associated with improved cytopenias in patients with relapsed/refractory inhl and CLL

Idelalisib treatment is associated with improved cytopenias in patients with relapsed/refractory inhl and CLL Idelalisib treatment is associated with improved cytopenias in patients with relapsed/refractory inhl and CLL Susan M O Brien, Andrew J Davies, Ian W Flinn, Ajay K Gopal, Thomas J Kipps, Gilles A Salles,

More information

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Hematology MOC exam blueprint Based on feedback from physicians that MOC assessments should

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423

More information

SHORT C. V. Meletios A. Dimopoulos, MD

SHORT C. V. Meletios A. Dimopoulos, MD SHORT C. V. Meletios A. Dimopoulos, MD Meletios A. Dimopoulos, MD is Professor and Chairman of the Department of Clinical at the National and Kapodistrian, Athens, Greece. He has been elected Vice Dean

More information

Careers in Pediatric Hematology/Oncology

Careers in Pediatric Hematology/Oncology Careers in Pediatric Hematology/Oncology Prepared by The American Society of Pediatric Hematology/Oncology ASPHO 8735 W. Higgins Rd., Suite 300, Chicago, IL 60631 847.375.4716 aspho.org ABOUT ASPHO The

More information

Dr. Julian Winocour, M.D., C.M., F.R.C.S.C.

Dr. Julian Winocour, M.D., C.M., F.R.C.S.C. Dr. Julian Winocour, M.D., C.M., F.R.C.S.C. Administrative Office: Vanderbilt University Medical Center Department of Plastic Surgery D-4207 Medical Center North Nashville, Tennessee 37232-2345 Phone (615)

More information

Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center

Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center MEDICAL ONCOLOGY AND HEMATOLOGY (R2, R3) A. The PURPOSE of this rotation is to afford medical residents a broad clinical and training experience in the clinical diagnosis and management of common adult

More information

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019 MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments

More information

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY 1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor

More information

2018 KSMO Immune Oncology Forum. Immune checkpoint inhibitors in hematologic. malignancies: evidences and perspectives 서울아산병원종양내과 홍정용

2018 KSMO Immune Oncology Forum. Immune checkpoint inhibitors in hematologic. malignancies: evidences and perspectives 서울아산병원종양내과 홍정용 2018 KSMO Immune Oncology Forum Immune checkpoint inhibitors in hematologic malignancies: evidences and perspectives 서울아산병원종양내과 홍정용 2018-07-18 Contents Introduction Immune checkpoint inhibtors in lymphomas

More information

CURRICULUM VITAE. Sarah Dobrozsi MD

CURRICULUM VITAE. Sarah Dobrozsi MD CURRICULUM VITAE MD Assistant Professor Department of Pediatrics Division of Hematology and Oncology - Pediatrics Date of Document: October 7, 2018 OFFICE ADDRESS: MACC Fund Research Center 8701 Watertown

More information

UPDATE Autologous Stem Cell Transplantation for Lymphoma and Myeloma

UPDATE Autologous Stem Cell Transplantation for Lymphoma and Myeloma UPDATE Autologous Stem Cell Transplantation for Lymphoma and Myeloma Supported by a grant from Supported by a grant from UPDATE Autologous Stem Cell Transplantation for Lymphoma and Myeloma Jonathan W.

More information

SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours.

SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours. SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE- Total hours number 70 hours, including course 0 hours, seminars 0 hours. Aim of the subject of Hematology: The study of etiology, pathogenesis,

More information

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1.

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral

More information

Lawrence K. Low, M.D., Ph.D.

Lawrence K. Low, M.D., Ph.D. Lawrence K. Low, M.D., Ph.D. CURRICULUM VITAE NAME Lawrence K. Low POSITION: Staff Pathologist, Alta East Bay Pathology ADDRESS: Alta Bates Summit Medical Center 350 Hawthorne Ave. Telephone: 510-869-6567

More information

BR for previously untreated or relapsed CLL

BR for previously untreated or relapsed CLL 1 Protocol synopsis Title Rationale Study Objectives Multicentre phase II trial of bendamustine in combination with rituximab for patients with previously untreated or relapsed chronic lymphocytic leukemia

More information

Samantha K. Holden, MD East 17th Avenue Campus Box B185 Aurora, CO Phone:

Samantha K. Holden, MD East 17th Avenue Campus Box B185 Aurora, CO Phone: EDUCATION Samantha K. Holden, MD University of Colorado Anschutz Medical Campus, Colorado Clinical and Translational Sciences Institute, Clinical Sciences Graduate Program, M.S. in Clinical Science. Expected

More information

CLL: A Guide for Patients and Caregivers CHRONIC LYMPHOCYTIC LEUKEMIA

CLL: A Guide for Patients and Caregivers CHRONIC LYMPHOCYTIC LEUKEMIA CLL: A Guide for Patients and Caregivers LEUKEMIA LYMPHOMA CHRONIC LYMPHOCYTIC LEUKEMIA MYELOMA Introduction In the U.S. In 2006, about 91,000 people were living with CLL In 2007, more than 15,000 people

More information

Nicole M. Burkemper, M.D. Assistant Professor

Nicole M. Burkemper, M.D. Assistant Professor Nicole M. Burkemper, M.D. Assistant Professor Office Address: Department of Dermatology 1402 South Grand Blvd. St. Louis, MO 63104 Place of Birth: St. Charles, Missouri Citizenship: United States Citizen

More information

CURRICULUM VITAE. San Diego Cancer Center/ Medical Group of North County, Inc. Encinitas, CA (760) (760) (760) fax

CURRICULUM VITAE. San Diego Cancer Center/ Medical Group of North County, Inc. Encinitas, CA (760) (760) (760) fax CURRICULUM VITAE Laurie A. Frakes, M.D. 477 N. El Camino Road Suite D200 Encinitas, CA 92024 California Cancer Associates for Research & Excellence, Inc. EDUCATION Fellowship Hematology/Oncology, Scripps

More information

Regence. Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT REMINDER

Regence. Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT REMINDER Regence Medicare Advantage Policy Manual Policy ID: M-TRA45 Stem Cell / Bone Marrow Transplants Published: 10/01/2018 Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT

More information

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 08/19/14 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 08/19/14 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE: RITUXAN (rituximab) Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline

More information

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Myeloproliferative Disorders - D Savage - 9 Jan 2002 Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2

More information

CURRICULUM VITAE. Ryan M Majcina, M.D. Date of version: March 1, 2017

CURRICULUM VITAE. Ryan M Majcina, M.D. Date of version: March 1, 2017 CURRICULUM VITAE Ryan M Majcina, M.D. Date of version: March 1, 2017 I. DEMOGRAPHIC INFORMATION Current appointment: Assistant Professor SIU Healthcare Department of Pediatrics Division of Critical Care

More information

Alexis M Cruz Chacón MD 383 Calle Melaleuca, Arboles de Montehiedra, San Juan PR Tel

Alexis M Cruz Chacón MD 383 Calle Melaleuca, Arboles de Montehiedra, San Juan PR Tel Alexis M Cruz Chacón MD 383 Calle Melaleuca, Arboles de Montehiedra, San Juan PR 00926 Tel. 787-448-4221 E-mail: acchacon@auxiliomutuo.com Employment History HOSPITAL ESPAÑOL AUXILIO MUTUO. San Juan, Puerto

More information

RITUXAN (rituximab and hyaluronidase human)

RITUXAN (rituximab and hyaluronidase human) Drug Prior Authorization Guideline RITUXIMAB products J9310 RITUXAN (rituximab and hyaluronidase human) PA9847 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria

More information

New Evidence reports on presentations given at EHA/ICML Bendamustine in the Treatment of Lymphoproliferative Disorders

New Evidence reports on presentations given at EHA/ICML Bendamustine in the Treatment of Lymphoproliferative Disorders New Evidence reports on presentations given at EHA/ICML 2011 Bendamustine in the Treatment of Lymphoproliferative Disorders Report on EHA/ICML 2011 presentations Efficacy and safety of bendamustine plus

More information

Education and Training

Education and Training Thomas Aaron O Neil, MD Clinical Lecturer Medical School thomasao@med.umich.edu Education and Training 2/2014 Essential Skills for Successful Leadership Faculty Career Development 7/2011-6/2012 Hospice

More information

JANUARY 22, :00 AM 4:30 PM

JANUARY 22, :00 AM 4:30 PM FRIDAY, JANUARY 22, 2016 8:00 AM 4:30 PM Hilton Hotel 4200 City Avenue Philadelphia, PA 19131 Penn Medicine s Abramson Cancer Center and the Leukemia & Lymphoma Society PRESENT UPDATE IN HEMATOLOGIC CANCERS

More information

Systematic Reviews in Hematological Malignancies

Systematic Reviews in Hematological Malignancies Systematic Reviews in Hematological Malignancies Pia Raanani, MD Davidoff Cancer Center Rabin Medical Center, Israel 1 2 Disorder CHMG Systematic review* Title Protocol Full Review Myelodysplastic syndrome

More information

Stem Cells And The Future of Regenerative Medicine. Dipnarine Maharaj, M. D., FACP

Stem Cells And The Future of Regenerative Medicine. Dipnarine Maharaj, M. D., FACP Stem Cells And The Future of Regenerative Medicine Dipnarine Maharaj, M. D., FACP The following potential conflict of interest relationships are germane to my presentation. Employment: South Florida Bone

More information

Chronic Myelogenous Leukemia (Hematology) By DEISSEROTH READ ONLINE

Chronic Myelogenous Leukemia (Hematology) By DEISSEROTH READ ONLINE Chronic Myelogenous Leukemia (Hematology) By DEISSEROTH READ ONLINE If searched for the ebook by DEISSEROTH Chronic Myelogenous Leukemia (Hematology) in pdf format, in that case you come on to correct

More information

Tristen Chun, MD, MS, MA

Tristen Chun, MD, MS, MA Tristen Chun, MD, MS, MA Armand D. Versaci Research Scholar /Surgical Resident AYALA LAB Division of Surgical Research Rhode Island Hospital Brown Medical School Aldrich 226, 593 Eddy Street Providence,

More information

MEGAN R. PRESCOTT, LCSW, NSW-C, BCC

MEGAN R. PRESCOTT, LCSW, NSW-C, BCC MEGAN R. PRESCOTT, LCSW, NSW-C, BCC megan.prescott@uchealth.org 720-848-0991 office 720-235-2400 cell Education 2012-2013 Foundational Program, Institute of Life Coach Training 2000-2002 Masters of Social

More information

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS WHAT IS TRUE AND WHAT IS FALSE? Questions 1 Iron deficiency anemia a) Is usually associated with a raised MCV. b) The MCH is usually low. c) Is most commonly due

More information

NAME: Boyd Jack Brew Hardigg

NAME: Boyd Jack Brew Hardigg NAME: Boyd Jack Brew Hardigg EDUCATION: POSTDOCTORAL Indiana University School of Medicine Thoracic Surgery Resident June 2009 Indiana University School of Medicine General Surgery Resident June 2006 Indiana

More information

Pediatric Hematology-Oncology

Pediatric Hematology-Oncology Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS

More information

HEMATOLOGY AND ONCOLOGY

HEMATOLOGY AND ONCOLOGY x THE POWER OF HEMATOLOGY AND ONCOLOGY Experts. Experience. Execution. A Deeper Dive into Hematology and Oncology Medpace supports our sponsors who are advancing new anti-cancer therapies by providing

More information

Shalini Mahajan, M.D. Director, LA Neuromuscular Center (LANMC) Attune Health, Beverly Hills, CA

Shalini Mahajan, M.D. Director, LA Neuromuscular Center (LANMC) Attune Health, Beverly Hills, CA Shalini Mahajan, M.D. Director, LA Neuromuscular Center (LANMC) Attune Health, Beverly Hills, CA Business Address LA Neuromuscular Center Attune Health 8750 Wilshire Blvd, Ste 350, Beverly Hills, CA 90211

More information

Leukemia (Perspectives On Disease And Illness) By Retold by:

Leukemia (Perspectives On Disease And Illness) By Retold by: Leukemia (Perspectives On Disease And Illness) By Retold by: If you are searching for the ebook Leukemia (Perspectives on Disease and Illness) by Retold by: in pdf format, then you have come on to faithful

More information

Distribution of Leukemia in Chennai Population:- An Epidemiological Study

Distribution of Leukemia in Chennai Population:- An Epidemiological Study Research Article Distribution of Leukemia in Chennai Population:- An Epidemiological Study Devika Warrier E*, MP Brundha Department of General Pathology, Saveetha University, 162, P.H Road, Chennai, Tamil

More information

4100: Cellular Therapy Essential Data Follow-Up Form

4100: Cellular Therapy Essential Data Follow-Up Form 4100: Cellular Therapy Essential Data Follow-Up Form Registry Use Only Sequence Number: Date Received: Key Fields CIBMTR Center Number: Event date: Visit: 100 day 6 months 1 year 2 years >2 years, Specify:

More information

Megan R. Prescott, LCSW, HEC-C

Megan R. Prescott, LCSW, HEC-C Megan R. Prescott, LCSW, HEC-C megan.prescott@uchealth.org 720-235-2400 Aurora, CO Education 2000-2002 Master of Social Work, CSU, Long Beach 1996-1999 Bachelor of Science in Sociology, CSU, Fullerton

More information

Rituxan (rituximab) DRUG POLICY BENEFIT APPLICATION

Rituxan (rituximab) DRUG POLICY BENEFIT APPLICATION DRUG POLICY BENEFIT APPLICATION Rituxan (rituximab) Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations or exceptions

More information

Board-certified periodontist with more than 10 years of clinical expertise.

Board-certified periodontist with more than 10 years of clinical expertise. 11620 Wilshire Blvd. Suite 340 Los Angeles, CA 90025 Phone: 888.853.7944 Fax: 213.478.0550 info@calmedeval.com Dr. Alon Frydman, DDS, Periodontist Board-Certified in Dentistry Board-certified periodontist

More information

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME approved: June 27, 2006; effective: July 1, 2007 ACGME approved focused revision: September 30, 2012; effective:

More information

David Evan Meyer, MD, MS Assistant Professor of Surgery Department of Surgery, Division of Acute Care Surgery McGovern Medical School at UTHealth

David Evan Meyer, MD, MS Assistant Professor of Surgery Department of Surgery, Division of Acute Care Surgery McGovern Medical School at UTHealth David Evan Meyer, MD, MS Assistant Professor of Surgery Department of Surgery, Division of Acute Care Surgery BUSINESS ADDRESS 6431 Fannin Street MSB 4.292 77030 OFFICE PHONE 713 500-7240 OFFICE FAX 713

More information

STEPHANIE ANNE WATTS M.S, CCC-SLP

STEPHANIE ANNE WATTS M.S, CCC-SLP STEPHANIE ANNE WATTS M.S, CCC-SLP 1017 E Crenshaw Street Tampa Florida, 33604 Srandall1@mail.usf.edu (727) 505-6875 EDUCATION Clinical Fellowship 2014-2015 Joy McCann Culverhouse Center for Swallowing

More information

CURRICULUM VITAE. RON D. SCHIFF, M..D., Ph.D. May 26, 2015

CURRICULUM VITAE. RON D. SCHIFF, M..D., Ph.D. May 26, 2015 CURRICULUM VITAE RON D. SCHIFF, M..D., Ph.D. May 26, 2015 ADDRESS: 6625 Stonington Drive Tampa, Florida 33647 RSchiff@SchiffBiomedicalConsulting.com TELEPHONE NUMBERS: Office (813) 978-8327 Cell (813)

More information

2018 UPDATE IN HEMATOLOGIC MALIGNANCIES with Proceedings from International Medical Meetings

2018 UPDATE IN HEMATOLOGIC MALIGNANCIES with Proceedings from International Medical Meetings FRIDAY, JANUARY 26, 2018 7:30 AM 4:30 PM Hilton Philadelphia City Avenue 4200 City Avenue Philadelphia, PA 19131 Penn Medicine s Abramson Cancer Center and the Leukemia & Lymphoma Society PRESENT 2018

More information

Donor Lymphocyte Infusion for Malignancies Treated with an Allogeneic Hematopoietic Stem-Cell Transplant

Donor Lymphocyte Infusion for Malignancies Treated with an Allogeneic Hematopoietic Stem-Cell Transplant Last Review Status/Date: September 2014 Page: 1 of 8 Malignancies Treated with an Allogeneic Description Donor lymphocyte infusion (DLI), also called donor leukocyte or buffy-coat infusion is a type of

More information

CLINICAL POLICY DEPARTMENT: Medical Management DOCUMENT NAME: JakafiTM REFERENCE NUMBER: NH.PHAR.98

CLINICAL POLICY DEPARTMENT: Medical Management DOCUMENT NAME: JakafiTM REFERENCE NUMBER: NH.PHAR.98 PAGE: 1 of 6 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted

More information

JENNIFER L. BARNES, B.S.

JENNIFER L. BARNES, B.S. JENNIFER L. BARNES, B.S. Division of Nutritional Sciences 420 Bevier Hall, 905 S. Goodwin Ave. Urbana, IL 61801 barnes2@illinois.edu, 815-685-1554 EDUCATION 2008- present Doctoral Student in Nutritional

More information

MIKE Y. JEONG, DO, MPH, CMD

MIKE Y. JEONG, DO, MPH, CMD MIKE Y. JEONG, DO, MPH, CMD 9811 W. CHARLESTON BLVD. SUITE 2-304 LAS VEGAS, NEVADA 89117 Answering Service (702) 464-7855 Cell phone (702) 960-9311 Fax (877) 211-3791 Email: mjeong.gma@gmail.com SUMMARY

More information

The University of Mississippi Medical Center The University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation

The University of Mississippi Medical Center The University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation The University of Mississippi Medical Center The University of Mississippi Health Care Pharmacy and Therapeutics Committee Medication Use Evaluation June 2012 Objective The goal of this medication use

More information

Scott. A. Gasiorek, MD

Scott. A. Gasiorek, MD Scott. A. Gasiorek, MD Certifications Board Certified June 1986 American Board of Radiology Therapeutic Radiology 1982 Diplomat of the National Board of Medical Examiners Licensure Georgia - #023600 (active)

More information

Kymriah. Kymriah (tisagenlecleucel) Description

Kymriah. Kymriah (tisagenlecleucel) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.101 Subject: Kymriah Page: 1 of 5 Last Review Date: September 20, 2018 Kymriah Description Kymriah

More information

: Ajou University College of Medicine, Suwon, Korea; Ajou University College of Medicine, Graduate

: Ajou University College of Medicine, Suwon, Korea; Ajou University College of Medicine, Graduate CURRICULUM VITAE NAME Hyun Woo Lee, M.D. EDUCATION 1991.3.-2001.2 : Ajou University College of Medicine, Suwon, Korea; Doctor of Medicine 2004.3-2006.2 Ajou University College of Medicine, Graduate School,

More information

Supplementary Appendix to manuscript submitted by Trappe, R.U. et al:

Supplementary Appendix to manuscript submitted by Trappe, R.U. et al: Supplementary Appendix to manuscript submitted by Trappe, R.U. et al: Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful

More information

Andrew Schorr: Dr. Young, for patients receiving initial treatment could you discuss the findings comparing horse ATG and rabbit ATG?

Andrew Schorr: Dr. Young, for patients receiving initial treatment could you discuss the findings comparing horse ATG and rabbit ATG? What s New in Aplastic Anemia Treatment American Society of Hematology Meeting December 2011 Dr. Neal S. Young Please remember the opinions expressed on Patient Power are not necessarily the views of our

More information

Dr Claire Burney, Lymphoma Clinical Fellow, Bristol Haematology and Oncology Centre, UK

Dr Claire Burney, Lymphoma Clinical Fellow, Bristol Haematology and Oncology Centre, UK EMBT LWP 2017-R-05 Research Protocol: Outcomes of patients treated with Ibrutinib post autologous stem cell transplant for mantle cell lymphoma. A retrospective analysis of the LWP-EBMT registry. Principle

More information

CURRICULUM VITAE BIOGRAPHICAL. Business Phone: (412) Business Fax: (412) EDUCATION and TRAINING

CURRICULUM VITAE BIOGRAPHICAL. Business Phone: (412) Business Fax: (412) EDUCATION and TRAINING Name: Lori E. Cherok, MS, RDN, LDN, CNSC CURRICULUM VITAE BIOGRAPHICAL Business Address: University of Pittsburgh 4042 Forbes Tower 15260 E-Mail Address: lcherok@pitt.edu Business Phone: (412) 383-6566

More information

MICHELLE C. GATES SIU School of Medicine Department of Psychiatry P.O. Box 19677, Springfield, IL

MICHELLE C. GATES SIU School of Medicine Department of Psychiatry P.O. Box 19677, Springfield, IL MICHELLE C. GATES SIU School of Medicine Department of Psychiatry P.O. Box 19677, Springfield, IL 62794-9677 217-545-3935 EDUCATION Fellowship Onco-Psychology Program 08/14-08/15 Department of Psychiatry

More information

An Overview of Blood and Marrow Transplantation

An Overview of Blood and Marrow Transplantation An Overview of Blood and Marrow Transplantation October 24, 2009 Stephen Couban Department of Medicine Dalhousie University Objectives What are the types of blood and marrow transplantation? Who may benefit

More information

Drug Resistance In Leukemia And Lymphoma III (Advances In Experimental Medicine And Biology) (v. 3) READ ONLINE

Drug Resistance In Leukemia And Lymphoma III (Advances In Experimental Medicine And Biology) (v. 3) READ ONLINE Drug Resistance In Leukemia And Lymphoma III (Advances In Experimental Medicine And Biology) (v. 3) READ ONLINE If you are searching for a ebook Drug Resistance in Leukemia and Lymphoma III (Advances in

More information

Myeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination

Myeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination Myeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination Arati V. Rao, M.D. Division of Medical Oncology and Geriatrics Duke University Medical Center Durham

More information

CURRICULUM VITAE. Associate Clinical Professor of Medicine, UCSF Medical Director, Acute Care for Elders Unit, San Francisco General Hospital

CURRICULUM VITAE. Associate Clinical Professor of Medicine, UCSF Medical Director, Acute Care for Elders Unit, San Francisco General Hospital CURRICULUM VITAE Name: Position: Address: Edgar Pierluissi Associate Clinical Professor of Medicine, UCSF Medical Director, Acute Care for Elders Unit, San Francisco General Hospital 1001 Potrero Avenue

More information

Tasigna. Tasigna (nilotinib) Description

Tasigna. Tasigna (nilotinib) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.77 Subject: Tasigna Page: 1 of 6 Last Review Date: March 16, 2018 Tasigna Description Tasigna (nilotinib)

More information

Lynn B. Bonifacio, MD, FPCP, DPSHBT National Kidney and Transplant Institute Philippines

Lynn B. Bonifacio, MD, FPCP, DPSHBT National Kidney and Transplant Institute Philippines Lynn B. Bonifacio, MD, FPCP, DPSHBT National Kidney and Transplant Institute Philippines 3. WBMT Workshop 14-15 November 2014 Cape Town, South Africa Department for Hematology and Medical Oncology Leipzig,

More information

UNMH Hematology/Oncology Clinical Privileges

UNMH Hematology/Oncology Clinical Privileges o Initial privileges (initial appointment) o Renewal of privileges (reappointment) o Expansion of privileges (modification) All new applicants must meet the following requirements as approved by the UNMH

More information

CURRICULUM VITA. STEVEN K. JACOBS, M.D., Ph.D.

CURRICULUM VITA. STEVEN K. JACOBS, M.D., Ph.D. CURRICULUM VITA STEVEN K. JACOBS, M.D., Ph.D. EDUCATION: 1970-1973 B.A. in Physiology University of California Berkeley, California 1973-1978 Ph.D. in Immunology State University of School of Medicine

More information

Tasigna. Tasigna (nilotinib) Description

Tasigna. Tasigna (nilotinib) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.77 Subject: Tasigna Page: 1of 5 Last Review Date: September 15, 2017 Tasigna Description Tasigna (nilotinib)

More information

Yescarta. Yescarta (axicabtagene ciloleucel) Description

Yescarta. Yescarta (axicabtagene ciloleucel) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.105 Subject: Yescarta Page: 1 of 5 Last Review Date: September 20, 2018 Yescarta Description Yescarta

More information

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types Oncology Nursing Sub-Specialty Module Reference: Gobel B. M., Triest-Robertson S. & Vogel W.H. (Eds). (205). Advanced Oncology Nursing Certificate Review and Resources Manual. Pittsburgh: Oncology Nursing

More information

Arzerra. Arzerra (ofatumumab) Description

Arzerra. Arzerra (ofatumumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.03 Subject: Arzerra Page: 1 of 5 Last Review Date: June 22, 2017 Arzerra Description Arzerra (ofatumumab)

More information

CURRICULUM VITAE. OFFICES: 1401 Avocado Avenue, Suite 506 Newport Beach, Ca (949)

CURRICULUM VITAE. OFFICES: 1401 Avocado Avenue, Suite 506 Newport Beach, Ca (949) CURRICULUM VITAE NAME: Gary Louis Wyatt OFFICES: 1401 Avocado Avenue, Suite 506 Newport Beach, Ca 92660 (949) 760-1661 BIRTHDATE: August 12, 1946 BIRTHPLACE: Long Beach, California EDUCATION: LICENSURE:

More information

Curriculum Vitae Carlos Emilio Picone, M.D., FACP, FCCP 5530 Wisconsin Ave. Suite 930 Chevy Chase, MD

Curriculum Vitae Carlos Emilio Picone, M.D., FACP, FCCP 5530 Wisconsin Ave. Suite 930 Chevy Chase, MD Curriculum Vitae Carlos Emilio Picone, M.D., FACP, FCCP 5530 Wisconsin Ave. Suite 930 Chevy Chase, MD 20815 cpicone@chevychasepulmonary.com Personal Information: Date of Birth: March 10, 1966 Place of

More information

Curriculum Vitae ARUN K. KALRA, MD

Curriculum Vitae ARUN K. KALRA, MD Curriculum Vitae ARUN K. KALRA, MD Office: CCARE California Cancer Associates in Research and Excellence 39755 Date St. Suite 103 Murrieta, California 92563 01/2017 to current. Arun Kalra MD Inc. 09/2016

More information

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data Key Fields Sequence Number: Date Received: - - CIBMTR Center Number: CIBMTR Recipient ID: Has this patient's data been previously reported to USIDNET? USIDNET ID: Today's Date: - - Date of HSCT for which

More information

Highlights from the 2017 Annual Meeting of the American Society of Hematology

Highlights from the 2017 Annual Meeting of the American Society of Hematology Latest NEWS IN BLOOD CANCER RESEARCH Highlights from the 2017 Annual Meeting of the American Society of Hematology CancerCare Connect Booklet Series www.cancercare.org The CancerCare Connect Booklet Series

More information

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF)

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) Colony Stimulating Factor (CSF) Neupogen (filgrastim; G-CSF), Neulasta (peg-filgrastim; G-CSF); Neulasa

More information

Dr.PSRK.Sastry MD, ECMO

Dr.PSRK.Sastry MD, ECMO Peripheral blood stem cell transplantation (Haematopoietic stem cell transplantation) Dr.PSRK.Sastry MD, ECMO Consultant, Medical Oncology Kokilaben Dhirubhai Ambani Hospital Normal hematopoiesis Historical

More information

THE ROLE OF TBI IN STEM CELL TRANSPLANTATION. Dr. Biju George Professor Department of Haematology CMC Vellore

THE ROLE OF TBI IN STEM CELL TRANSPLANTATION. Dr. Biju George Professor Department of Haematology CMC Vellore THE ROLE OF TBI IN STEM CELL TRANSPLANTATION Dr. Biju George Professor Department of Haematology CMC Vellore Introduction Radiotherapy is the medical use of ionising radiation. TBI or Total Body Irradiation

More information

2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist?

2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist? Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Colony Stimulating Factors (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review

More information

With Proceedings from International Medical Meetings

With Proceedings from International Medical Meetings Penn Medicine s Abramson Cancer Center and the Leukemia & Lymphoma Society PRESENT UPDATE IN HEMATOLOGIC CANCERS With Proceedings from International Medical Meetings REGISTER ONLINE AT PENNCANCER.ORG/CME/BLOOD

More information

An D. Nguyen, MD Curriculum Vitae

An D. Nguyen, MD Curriculum Vitae OFFICE/ BUSINESS ADDRESS: Pacific Shores Medical Group 19582 Beach Blvd, Suite 212 Huntington Beach, CA 92648 Phone: (714) 252-9415 Fax: (714) 963-8407 ADDITIONAL OFFICE: 16300 Sand Canyon Avenue, Suite

More information

Dr Shankara Paneesha. ASH Highlights Department of Haematology & Stem cell Transplantation

Dr Shankara Paneesha. ASH Highlights Department of Haematology & Stem cell Transplantation ASH Highlights 2015 Themes of ASH 2015 Novel therapies - Myeloma AML Lymphoma Pd-L1 & PD-l inhibitors Emerging concepts in biology HIF-1a pathway Cautionary tales ASH Choosing Wisely list IFM/DFCI

More information

[COMPREHENSIVE GENETIC ASSAY PANEL ON

[COMPREHENSIVE GENETIC ASSAY PANEL ON 2014 SN GENELAB AND RESEARCH CENTER DR. SALIL VANIAWALA, PH.D [COMPREHENSIVE GENETIC ASSAY PANEL ON MYELOPROLIFERATIVE NEOPLASMS] SN Genelab presents one of the most comprehensive genetic assay panel for

More information